Literature DB >> 26134840

Genetics of Primary Inherited Disorders of the Optic Nerve: Clinical Applications.

Keri F Allen1, Eric D Gaier1, Janey L Wiggs1.   

Abstract

Inherited disorders of the optic nerve significantly impact vision in children and adults. The optic nerve disorders most commonly encountered clinically are glaucoma and primary optic neuropathy including Leber's hereditary optic neuropathy (LHON) and autosomal dominant or Kjer's optic atrophy. Current knowledge of the genetics of optic neuropathy and glaucoma makes it possible to test for mutations in disease-causing genes allowing for presymptomatic testing and risk assessment, and recent advances have revealed important disease mechanisms that may suggest potential therapeutic targets. In this perspective, we describe the current approaches and limitations to genetic testing for these disorders and provide an update on the development of gene-based therapies.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26134840      PMCID: PMC4484958          DOI: 10.1101/cshperspect.a017277

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  57 in total

Review 1.  Glaucoma: genes, phenotypes, and new directions for therapy.

Authors:  Bao Jian Fan; Janey L Wiggs
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 2.  Cell transplantation approaches to retinal ganglion cell neuroprotection in glaucoma.

Authors:  Thomas V Johnson; Keith R Martin
Journal:  Curr Opin Pharmacol       Date:  2012-08-29       Impact factor: 5.547

3.  Genomic deletions in OPA1 in Danish patients with autosomal dominant optic atrophy.

Authors:  Gitte J Almind; Karen Grønskov; Dan Milea; Michael Larsen; Karen Brøndum-Nielsen; Jakob Ek
Journal:  BMC Med Genet       Date:  2011-04-04       Impact factor: 2.103

4.  Trial end points and natural history in patients with G11778A Leber hereditary optic neuropathy : preparation for gene therapy clinical trial.

Authors:  Byron L Lam; William J Feuer; Joyce C Schiffman; Vittorio Porciatti; Ruth Vandenbroucke; Potyra R Rosa; Giovanni Gregori; John Guy
Journal:  JAMA Ophthalmol       Date:  2014-04-01       Impact factor: 7.389

5.  Null CYP1B1 genotypes in primary congenital and nondominant juvenile glaucoma.

Authors:  María-Pilar López-Garrido; Cristina Medina-Trillo; Laura Morales-Fernandez; Julián Garcia-Feijoo; José-María Martínez-de-la-Casa; Maite García-Antón; Julio Escribano
Journal:  Ophthalmology       Date:  2012-12-04       Impact factor: 12.079

6.  Gln368STOP myocilin mutation in families with late-onset primary open-angle glaucoma.

Authors:  R R Allingham; J L Wiggs; M A De La Paz; D Vollrath; D A Tallett; B Broomer; K H Jones; E A Del Bono; J Kern; K Patterson; J L Haines; M A Pericak-Vance
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-11       Impact factor: 4.799

7.  Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.

Authors:  Marc Ferré; Dominique Bonneau; Dan Milea; Arnaud Chevrollier; Christophe Verny; Hélène Dollfus; Carmen Ayuso; Sabine Defoort; Catherine Vignal; Xavier Zanlonghi; Jean-Francois Charlin; Josseline Kaplan; Sylvie Odent; Christian P Hamel; Vincent Procaccio; Pascal Reynier; Patrizia Amati-Bonneau
Journal:  Hum Mutat       Date:  2009-07       Impact factor: 4.878

8.  Prevalence and spectrum of PITX2c mutations associated with congenital heart disease.

Authors:  Juan Wang; Yuan-Feng Xin; Wen-Jun Xu; Zhong-Min Liu; Xing-Biao Qiu; Xin-Kai Qu; Lei Xu; Xin Li; Yi-Qing Yang
Journal:  DNA Cell Biol       Date:  2013-10-01       Impact factor: 3.311

9.  TBK1 gene duplication and normal-tension glaucoma.

Authors:  Robert Ritch; Ben Darbro; Geeta Menon; Cheryl L Khanna; Frances Solivan-Timpe; Ben R Roos; Mansoor Sarfarzi; Kazuhide Kawase; Tetsuya Yamamoto; Alan L Robin; Andrew J Lotery; John H Fingert
Journal:  JAMA Ophthalmol       Date:  2014-05       Impact factor: 7.389

10.  Gene-environment interactions in Leber hereditary optic neuropathy.

Authors:  Matthew Anthony Kirkman; Patrick Yu-Wai-Man; Alex Korsten; Miriam Leonhardt; Konstantin Dimitriadis; Ireneaus F De Coo; Thomas Klopstock; Patrick Francis Chinnery
Journal:  Brain       Date:  2009-06-12       Impact factor: 13.501

View more
  10 in total

1.  Angiopoietin receptor TEK mutations underlie primary congenital glaucoma with variable expressivity.

Authors:  Tomokazu Souma; Stuart W Tompson; Benjamin R Thomson; Owen M Siggs; Krishnakumar Kizhatil; Shinji Yamaguchi; Liang Feng; Vachiranee Limviphuvadh; Kristina N Whisenhunt; Sebastian Maurer-Stroh; Tammy L Yanovitch; Luba Kalaydjieva; Dimitar N Azmanov; Simone Finzi; Lucia Mauri; Shahrbanou Javadiyan; Emmanuelle Souzeau; Tiger Zhou; Alex W Hewitt; Bethany Kloss; Kathryn P Burdon; David A Mackey; Keri F Allen; Jonathan B Ruddle; Sing-Hui Lim; Steve Rozen; Khanh-Nhat Tran-Viet; Xiaorong Liu; Simon John; Janey L Wiggs; Francesca Pasutto; Jamie E Craig; Jing Jin; Susan E Quaggin; Terri L Young
Journal:  J Clin Invest       Date:  2016-06-06       Impact factor: 14.808

Review 2.  Genetics of glaucoma.

Authors:  Janey L Wiggs; Louis R Pasquale
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

3.  EFEMP1 rare variants cause familial juvenile-onset open-angle glaucoma.

Authors:  Edward Ryan A Collantes; Manuel S Delfin; Baojian Fan; Justine May R Torregosa; Christine Siguan-Bell; Nilo Vincent de Guzman Florcruz; Jose Maria D Martinez; Barbara Joy Masna-Hidalgo; Vincent Paul T Guzman; Jewel Faith Anotado-Flores; Faye D Levina; Sophia Raine C Hernandez; Anthony A Collantes; Michael Carreon Sibulo; Shisong Rong; Janey L Wiggs
Journal:  Hum Mutat       Date:  2021-12-28       Impact factor: 4.878

4.  Exome sequencing identified a novel de novo OPA1 mutation in a consanguineous family presenting with optic atrophy.

Authors:  Lior Cohen; Shay Tzur; Nitza Goldenberg-Cohen; Concetta Bormans; Doron M Behar; Eyal Reinstein
Journal:  Genet Res (Camb)       Date:  2016-06-06       Impact factor: 1.588

Review 5.  Childhood glaucoma genes and phenotypes: Focus on FOXC1 mutations causing anterior segment dysgenesis and hearing loss.

Authors:  Angela C Gauthier; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2019-12-11       Impact factor: 3.467

Review 6.  Clinical implications of recent advances in primary open-angle glaucoma genetics.

Authors:  Hélène Choquet; Janey L Wiggs; Anthony P Khawaja
Journal:  Eye (Lond)       Date:  2019-10-23       Impact factor: 3.775

Review 7.  Role of glia in optic nerve.

Authors:  Meysam Yazdankhah; Peng Shang; Sayan Ghosh; Stacey Hose; Haitao Liu; Joseph Weiss; Christopher S Fitting; Imran A Bhutto; J Samuel Zigler; Jiang Qian; José-Alain Sahel; Debasish Sinha; Nadezda A Stepicheva
Journal:  Prog Retin Eye Res       Date:  2020-08-06       Impact factor: 21.198

8.  Diagnostic genetic testing for patients with bilateral optic neuropathy and comparison of clinical features according to OPA1 mutation status.

Authors:  Eric D Gaier; Katherine Boudreault; Isao Nakata; Maria Janessian; Philip Skidd; Elizabeth DelBono; Keri F Allen; Louis R Pasquale; Emily Place; Dean M Cestari; Rebecca C Stacy; Joseph F Rizzo; Janey L Wiggs
Journal:  Mol Vis       Date:  2017-08-10       Impact factor: 2.367

9.  Novel mutations in LTBP2 identified in familial cases of primary congenital glaucoma.

Authors:  Bushra Rauf; Bushra Irum; Shahid Y Khan; Firoz Kabir; Muhammad Asif Naeem; Sheikh Riazuddin; Radha Ayyagari; S Amer Riazuddin
Journal:  Mol Vis       Date:  2020-02-24       Impact factor: 2.367

10.  SVEP1 as a Genetic Modifier of TEK-Related Primary Congenital Glaucoma.

Authors:  Terri L Young; Kristina N Whisenhunt; Jing Jin; Sarah M LaMartina; Sean M Martin; Tomokazu Souma; Vachiranee Limviphuvadh; Fatemeh Suri; Emmanuelle Souzeau; Xue Zhang; Yongwook Dan; Evie Anagnos; Susana Carmona; Nicole M Jody; Nickie Stangel; Emily C Higuchi; Samuel J Huang; Owen M Siggs; Maria José Simões; Brendan M Lawson; Jacob S Martin; Elahe Elahi; Mehrnaz Narooie-Nejad; Behzad Fallahi Motlagh; Susan E Quaggin; Heather D Potter; Eduardo D Silva; Jamie E Craig; Conceição Egas; Reza Maroofian; Sebastian Maurer-Stroh; Yasmin S Bradfield; Stuart W Tompson
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-10-01       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.